Cells, Tissues and ATMP and Alternative Microbiological Methods (Tag 2) This conference is part of PharmaLab Congress 2022

Cells, Tissues and ATMP and Alternative Microbiological Methods (Tag 2)

Neuss, Germany

Seminar Nr. 20310



Regular Fee*: EUR 690,--
EU/GMP Inspectorates*: EUR 345,--

Alle Preise zzgl. MwSt.

* auch unkompliziert per Kreditkarte bezahlbar American Express Visa Mastercard

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de


09.15 - 10.00 h
Congress Keynote: Impurities - USP Draft Chapter <477> User-Determined Reporting Thresholds (UDRT), and Other Relevant Chapters
Dr Christian Zeine, Senior Manager Scientific Affairs EMEA

Microbiological Control of ATMP
Chiemezie Nwakire, Neuroplast

Implementation of a Comprehensive Rapid Microbial Contamination Control Platform for Testing of Sterile Pharmaceuticals and Cell-Based Therapies using ATP Bioluminescence
Stefan Gärtner, Labor LS
Lucia Ceresa, CRL

Ultra-Rapid Microbial Detection in Cell & Gene Therapy Products: the closest you can be to Real-Time Release
Corinne de la Foata, bioMerieux

Viral Safety – Evaluation of Eukaryotic Cell Bank Purity with a Special Focus on Adventitious Agents and Replication Competent Viruses
Larissa Nkenmei-Pietsch, Tentamus

Short Shelf Life and Sterility Testing - Challenges of Cell Based ATMP Market Supply
Debora D`Amico, Tetec

Rapid Sterility by qPCR for ATMPs
Dr Anja Fritsch, Confarma

ScanRDI System - Validation and Implementation of an Alternative Sterility Test (Solid Phase Cytometry) for a Cell and Gene Therapy Product
Mahsa Mohammadi, Novartis

Implementation of a Real Time PCR-based Method for Release Testing the Sterility of ATMPs, a Practical Approach
Yasmin Heynen, Labor LS


GMP Seminare nach Thema